Cloudsdale Ian S, Dickson John K, Barta Thomas E, Grella Brian S, Smith Emilie D, Kulp John L, Guarnieri Frank, Kulp John L
BioLeap, Inc., 6350 Quadrangle Drive, Suite 110, Chapel Hill, NC 27517, United States.
BioLeap, Inc., 6350 Quadrangle Drive, Suite 110, Chapel Hill, NC 27517, United States.
Bioorg Med Chem. 2017 Aug 1;25(15):3947-3963. doi: 10.1016/j.bmc.2017.05.032. Epub 2017 May 19.
We have applied simulated annealing of chemical potential (SACP) to a diverse set of ∼150 very small molecules to provide insights into new interactions in the binding pocket of human renin, a historically difficult target for which to find low molecular weight (MW) inhibitors with good bioavailability. In one of its many uses in drug discovery, SACP provides an efficient, thermodynamically principled method of ranking chemotype replacements for scaffold hopping and manipulating physicochemical characteristics for drug development. We introduce the use of Constrained Fragment Analysis (CFA) to construct and analyze ligands composed of linking those fragments with predicted high affinity. This technique addresses the issue of effectively linking fragments together and provides a predictive mechanism to rank order prospective inhibitors for synthesis. The application of these techniques to the identification of novel inhibitors of human renin is described. Synthesis of a limited set of designed compounds provided potent, low MW analogs (ICs<100nM) with good oral bioavailability (F>20-58%).
我们已将化学势模拟退火(SACP)应用于约150种不同的非常小的分子,以深入了解人肾素结合口袋中的新相互作用。人肾素一直是一个难以找到具有良好生物利用度的低分子量(MW)抑制剂的靶点。在药物发现的众多用途中,SACP提供了一种高效、基于热力学原理的方法,用于对用于骨架跃迁的化学型替代物进行排序,并为药物开发操纵物理化学特性。我们引入了约束片段分析(CFA)的方法,以构建和分析由那些预测具有高亲和力的片段连接而成的配体。该技术解决了将片段有效连接在一起的问题,并提供了一种预测机制,用于对预期的抑制剂进行合成排序。描述了这些技术在鉴定人肾素新型抑制剂中的应用。合成了一组有限的设计化合物,得到了具有良好口服生物利用度(F>20 - 58%)的强效、低MW类似物(IC₅₀<100nM)。